For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220301:nRSA2260Da&default-theme=true
RNS Number : 2260D Integrated Diagnostics Holdings PLC 01 March 2022
Integrated Diagnostics Holdings PLC
1 March 2022
Integrated Diagnostic Holdings plc (the "Company")
Directorate Change
The Board announces the appointment of Ms Yvonne Stillhart, as a Non-Executive
Director of the Company with effect from 1 March 2022. Yvonne also joins the
Audit and the Remuneration Committees.
Yvonne is a seasoned Senior Executive working with innovation and growth
driven companies across a wide range of industries and geographical regions,
including Europe, USA, North Africa and Sub-Sahara Africa. She has been a
Non-Executive Director and Audit and Risk Committee Member for more than 12
years. She has co-founded and led as a Senior Partner a specialised private
equity manager in Switzerland. For several decades Yvonne has been a senior
executive leader in international businesses, private market and
infrastructure investments. She is focussed on business building and
transformation, risk management and ESG governance.
Yvonne serves currently as a non-executive Director of UBS Asset Management
Switzerland Ltd. and is the Chairperson of the South African EPE Capital Ltd.
She is also on the Board of Standard Life Private Equity Trust Plc.
Yvonne holds a Director Certificate from Harvard Business School, the
Corporate Risk Certificate from the DCRO Institute and the ESG Competent
Boards Certificate.
Yvonne replaces James Nolan who resigned on 1 September 2021.
There are no other details that are required to be disclosed under the
Financial Conduct Authority LR 9.6.13 of the Listing Rules in relation to this
appointment.
For further information please contact:
Integrated Diagnostic Holdings plc
+20(0)2 3345 5530
Nancy Fahmy
Investor Relations Director
Company Secretary: IDHLondon@linkgroup.co.uk
Link Company Matters Limited
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOAUPUBPWUPPGWG